EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Comparing the diagnostic accuracy of Afirma GSC to ThyroSeq V3 in cytologically indeterminate thyroid nodules

Natasha Dowell iD, Shayma Begum iD, Jameel Muzaffar iD, Kristien Boelaert iD, Hannah Nieto iD

European Thyroid Journal · 01.12.2025 · 14 (6)

DOI: 10.1530/etj-25-0296 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Thyroid Journal, online erschienen am 28.11.2025. Verfasst von Natasha Dowell und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Health, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Thyroid Nodule. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the diagnostic test accuracy of Afirma GSC and ThyroSeq v3 in cytologically indeterminate thyroid nodules.

Methods

PubMed, Embase, Cochrane Library, Medline, and the Web of Science were searched from the date of inception to May 9, 2025. Two independent reviewers screened articles for eligibility. Studies assessing Afirma gene sequencing classifier (GSC) or ThyroSeq v3 for indeterminate thyroid nodules were included. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis reporting guidelines were followed. Statistical analysis was performed using R.

Results

A total of 26 studies met the eligibility criteria. For surgically confirmed Afirma GSC results, the sensitivity, specificity, and negative predictive value (NPV) were 94, 42, and 96%, respectively. For unoperated negative cases, the values were 96, 86, and 99%. For ThyroSeq v3, the sensitivity, specificity, and NPV for surgically confirmed cases were 96, 40, and 93%, respectively, and for unoperated negative cases, they were 97, 83, and 99%.

Conclusion

Both molecular tests demonstrate high NPV but low specificity; neither is clearly superior. Future research should prioritise randomised controlled trials, long-term follow-up of unoperated nodules, and direct comparisons of molecular tests.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NoduleHumansSensitivity and SpecificityPredictive Value of Tests

Stichwörter der Autor:innen

thyroidthyroid cancerthyroid nodule

Autor:innen und Institutionen

  • College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Department of Ear, Nose and Throat Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Department of Applied Health, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, UK.

ORCID-Profile: Natasha Dowell, Shayma Begum, Jameel Muzaffar, Kristien Boelaert, Hannah Nieto

Zitieren

APA

Dowell, N., Begum, S., Muzaffar, J., Boelaert, K., & Nieto, H. (2025). Comparing the diagnostic accuracy of Afirma GSC to ThyroSeq V3 in cytologically indeterminate thyroid nodules. European Thyroid Journal, 14(6). https://doi.org/10.1530/etj-25-0296

Vancouver

Dowell N, Begum S, Muzaffar J, Boelaert K, Nieto H. Comparing the diagnostic accuracy of Afirma GSC to ThyroSeq V3 in cytologically indeterminate thyroid nodules. European Thyroid Journal. 2025;14(6). doi:10.1530/etj-25-0296

BibTeX
@article{Dowell2025,
  author = {Dowell, Natasha and Begum, Shayma and Muzaffar, Jameel and Boelaert, Kristien and Nieto, Hannah},
  title = {Comparing the diagnostic accuracy of Afirma GSC to ThyroSeq V3 in cytologically indeterminate thyroid nodules},
  journal = {European Thyroid Journal},
  year = {2025},
  volume = {14},
  number = {6},
  doi = {10.1530/etj-25-0296}
}
Kostenlos starten →